Exxonmobil Holdings Corporation · XOM · FY2024 Q2 · Calendar Q3 2024
ExxonMobil’s Q2 combined record production with rapid Pioneer integration and higher planned capital spending
The supplied Q2 analysis presents ExxonMobil’s operating scale and Pioneer integration as near-term supports, while execution on elevated investment and commercialization of newer product and low-carbon initiatives remain important tests. The transcript supports a constructive operating picture, but does not remove exposure to commodity cycles or project and regulatory execution.
Research this report with FN2. Free to start; review your question before sending.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about XOM FY2024 Q2
Choose a question to continue your researchFree to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, the Q2 discussion adds that the Pioneer acquisition closed in six months and that early integration was exceeding expectations. Management also highlighted expanded performance-product opportunities and set legacy capital spending at the top end of its range, in addition to Pioneer.
Guidance delta
Overall guidance sentiment was characterized as maintained. The analysis describes legacy capex at the top end of the $25 billion range, plus Pioneer; it does not indicate a broader guidance revision.
Key takeaways
- Record production in Guyana and the Permian supported the strong operating picture described in the analysis.
- Pioneer integration was completed in six months, with early performance and cost synergies highlighted by management.
- Proxxima, carbon materials and Vistamaxx broaden the high-performance product opportunity set, though commercialization remains an execution item.
- Capital spending at the top end of the legacy range, alongside Pioneer, raises the importance of returns and delivery against planned projects.
Management priorities
- Capture operating and cost synergies from Pioneer integration.
- Advance high-performance products, including Proxxima and carbon materials, toward commercial scale.
- Execute the planned 2025 project start-ups while progressing low-carbon initiatives subject to regulatory clarity.
- Continue cost-efficiency efforts toward the stated 2027 savings objective.
Follow XOM with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Bernstein | Outperform | Outperform | Maintain | Nov 12, 2026 |
| Freedom Broker | Hold | Hold | Maintain | Nov 6, 2026 |
| TD Cowen | Buy | Buy | Maintain | Nov 4, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Nov 4, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Nov 2, 2026 |
| UBS | Buy | Buy | Maintain | Nov 2, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Nov 2, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Nov 2, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 19, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Sep 3, 2026 |
| B of A Securities | Neutral | Buy | Downgrade | Jul 28, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Jul 9, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | May 5, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Apr 22, 2026 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Apr 21, 2026 |
| BNP Paribas | Neutral | Underperform | Upgrade | Apr 17, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Apr 9, 2026 |
| Jefferies | Buy | Buy | Maintain | Apr 9, 2026 |
| HSBC | Hold | Hold | Maintain | Mar 20, 2026 |
| Freedom Capital Markets | Sell | Hold | Downgrade | Jan 6, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Aug 8, 2025 |
| Truist Securities | Hold | Hold | Maintain | Jan 13, 2025 |
| Exane BNP Paribas | Underperform | Neutral | Downgrade | Oct 9, 2024 |
| BMO Capital | Market Perform | Market Perform | Maintain | Oct 4, 2024 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Sep 24, 2024 |
| Erste Group | Hold | Buy | Downgrade | Dec 22, 2023 |
| Redburn Partners | Neutral | Sell | Upgrade | Aug 31, 2023 |
| Argus Research | Buy | Buy | Maintain | Feb 6, 2023 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Feb 2, 2023 |
| B. Riley Securities | Buy | Buy | Maintain | Feb 2, 2023 |
| Credit Suisse | Outperform | Neutral | Upgrade | Jun 21, 2022 |
| MKM Partners | Buy | Buy | Maintain | Mar 7, 2022 |
| DZ Bank | Hold | Buy | Downgrade | Aug 3, 2021 |
| Raymond James | Market Perform | Underperform | Upgrade | Apr 14, 2021 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Jul 24, 2020 |
| CFRA | Sell | Hold | Downgrade | Apr 30, 2020 |
| Berenberg | Hold | Hold | Maintain | Oct 7, 2019 |
| Tudor Pickering | Hold | Hold | Maintain | Apr 8, 2019 |
| Macquarie | Outperform | Underperform | Upgrade | Feb 14, 2019 |
| Societe Generale | Buy | Buy | Maintain | Dec 19, 2018 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| Bank of America | Buy | Buy | Maintain | Mar 8, 2018 |
| Imperial Capital | Outperform | Outperform | Maintain | Nov 15, 2017 |
| Scotia Howard Weil | Sector Outperform | Sector Perform | Upgrade | Jun 5, 2017 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 29, 2016 |
| Nomura | Sell | Reduce | Maintain | Mar 18, 2016 |
| Simmons & Co. | Neutral | Overweight | Downgrade | Aug 13, 2014 |
| ISI Group | Strong Buy | Buy | Upgrade | Feb 14, 2014 |
| S&P Capital IQ | Hold | Buy | Downgrade | Jan 10, 2014 |
| Oppenheimer | Perform | Outperform | Downgrade | Apr 2, 2013 |
| Phoenix Partners Group | Hold | Hold | Maintain | Mar 26, 2013 |
| Canaccord Genuity | Hold | Hold | Maintain | Feb 22, 2013 |
| Dahlman Rose | Buy | Buy | Maintain | Oct 10, 2012 |
| VTB Capital | Hold | Hold | Maintain | Sep 27, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $159.99. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Freedom Broker | Sergey Pigarev | $162 | $165.87 | +1.3% | Nov 6, 2026 |
| Bank of America Securities | Analyst unavailable | $181 | $178.09 | +13.1% | Oct 21, 2026 |
| Goldman Sachs | Neil Mehta | $178 | $178.29 | +11.3% | Oct 20, 2026 |
| UBS | Manav Gupta | $199 | $177.42 | +24.4% | Oct 19, 2026 |
| J.P. Morgan | Analyst unavailable | $186 | $178.28 | +16.3% | Oct 19, 2026 |
| Goldman Sachs | Neil Mehta | $169 | $177.3 | +5.6% | Oct 16, 2026 |
| UBS | Analyst unavailable | $172 | $162.05 | +7.5% | Sep 25, 2026 |
| Piper Sandler | Analyst unavailable | $185 | $164.17 | +15.6% | Sep 3, 2026 |
| Morgan Stanley | Analyst unavailable | $177 | $167.97 | +10.6% | Aug 19, 2026 |
| Barclays | Analyst unavailable | $177 | $160.09 | +10.6% | Aug 17, 2026 |
| UBS | Analyst unavailable | $168 | $154.83 | +5.0% | Aug 7, 2026 |
| HSBC | Analyst unavailable | $158 | $155.46 | -1.2% | Aug 3, 2026 |
| Wells Fargo | Sam Margolin | $182 | $155.46 | +13.8% | Aug 3, 2026 |
| Piper Sandler | John Royall | $158 | $154.45 | -1.2% | Jul 23, 2026 |
| Mizuho Securities | Analyst unavailable | $170 | $140.94 | +6.3% | Jul 9, 2026 |
| Mizuho Securities | Analyst unavailable | $175 | $149.85 | +9.4% | May 27, 2026 |
| Barclays | Betty Jiang | $182 | $154.92 | +13.8% | May 26, 2026 |
| Bernstein | Bob Brackett | $182 | $144.39 | +13.8% | May 11, 2026 |
| UBS | Analyst unavailable | $174 | $152.4 | +8.8% | May 4, 2026 |
| Morgan Stanley | Analyst unavailable | $171 | $143.53 | +6.9% | Apr 17, 2026 |
| BNP Paribas | Lucas Herrmann | $165 | $151.85 | +3.1% | Apr 17, 2026 |
| RBC Capital | Analyst unavailable | $180 | $155.04 | +12.5% | Apr 9, 2026 |
| Jefferies | Analyst unavailable | $184 | $155.04 | +15.0% | Apr 9, 2026 |
| Piper Sandler | Ryan Todd | $182 | $155.04 | +13.8% | Apr 9, 2026 |
| Wells Fargo | Sam Margolin | $185 | $155.04 | +15.6% | Apr 9, 2026 |
| Wolfe Research | Doug Leggate | $153 | $156.22 | -4.4% | Apr 8, 2026 |
| Morgan Stanley | Analyst unavailable | $172 | $170.99 | +7.5% | Mar 27, 2026 |
| Wells Fargo | Sam Margolin | $183 | $150.83 | +14.4% | Feb 24, 2026 |
| BMO Capital | Analyst unavailable | $155 | $143.78 | -3.1% | Feb 4, 2026 |
| Mizuho Securities | Analyst unavailable | $140 | $143.78 | -12.5% | Feb 4, 2026 |
| Loop Capital Markets | Sergey Pigarev | $123 | $143.92 | -23.1% | Feb 3, 2026 |
| Barclays | Analyst unavailable | $145 | $138.36 | -9.4% | Feb 3, 2026 |
| BNP Paribas | Analyst unavailable | $125 | $138.36 | -21.9% | Feb 3, 2026 |
| RBC Capital | Analyst unavailable | $150 | $139.14 | -6.2% | Feb 2, 2026 |
| UBS | Analyst unavailable | $171 | $141.63 | +6.9% | Feb 2, 2026 |
| Morgan Stanley | Devin McDermott | $134 | $135.57 | -16.2% | Jan 23, 2026 |
| Barclays | Betty Jiang | $140 | $132.78 | -12.5% | Jan 21, 2026 |
| Piper Sandler | Analyst unavailable | $142 | $118.49 | -11.2% | Jan 8, 2026 |
| Bernstein | Analyst unavailable | $137 | $122.65 | -14.4% | Jan 5, 2026 |
| Mizuho Securities | Analyst unavailable | $132 | $119.54 | -17.5% | Dec 12, 2025 |
| Wells Fargo | Analyst unavailable | $158 | $119.54 | -1.2% | Dec 11, 2025 |
| Jefferies | Analyst unavailable | $148 | $119 | -7.5% | Dec 10, 2025 |
| Morgan Stanley | Devin McDermott | $137 | $118.23 | -14.4% | Dec 10, 2025 |
| Scotiabank | Analyst unavailable | $155 | $114.31 | -3.1% | Nov 3, 2025 |
| UBS | Analyst unavailable | $145 | $110.73 | -9.4% | Oct 13, 2025 |
| Scotiabank | Analyst unavailable | $128 | $113.84 | -20.0% | Oct 9, 2025 |
| Piper Sandler | Analyst unavailable | $141 | $113.39 | -11.9% | Oct 7, 2025 |
| Barclays | Betty Jiang | $126 | $114.2 | -21.2% | Oct 7, 2025 |
| Mizuho Securities | Nitin Kumar | $123 | $112.35 | -23.1% | Sep 15, 2025 |
| Wells Fargo | Roger Read | $127 | $108.37 | -20.6% | Jun 26, 2025 |
| Barclays | Betty Jiang | $127 | $103.27 | -20.6% | May 5, 2025 |
| Barclays | Betty Jiang | $130 | $107.37 | -18.7% | Apr 23, 2025 |
| Morgan Stanley | Analyst unavailable | $138 | $118.27 | -13.7% | Mar 26, 2025 |
| Mizuho Securities | Nitin Kumar | $137 | $121.84 | -14.4% | Nov 14, 2024 |
| Bank of America Securities | Jean Ann Salisbury | $124 | $120.66 | -22.5% | Oct 17, 2024 |
| Scotiabank | Paul Cheng | $145 | $123.27 | -9.4% | Oct 10, 2024 |
| Scotiabank | Paul Cheng | $129 | $124.83 | -19.4% | Oct 4, 2024 |
| Mizuho Securities | Nitin Kumar | $130 | $124.83 | -18.7% | Oct 4, 2024 |
| Barclays | Betty Jiang | $137 | $119.93 | -14.4% | Oct 2, 2024 |
| Truist Financial | Neal Dingmann | $117 | $115.82 | -26.9% | Sep 30, 2024 |
| Redburn Partners | Peter Low | $120 | $117.36 | -25.0% | Sep 24, 2024 |
| Goldman Sachs | Neil Mehta | $118 | $111.15 | -26.2% | Sep 16, 2024 |
| Wolfe Research | Doug Leggate | $146 | $117.64 | -8.7% | Jul 17, 2024 |
| UBS | Josh Silverstein | $154 | $114.05 | -3.7% | Jun 25, 2024 |
| Truist Financial | Neal Dingmann | $124 | $113.97 | -22.5% | Jun 7, 2024 |
| UBS | Josh Silverstein | $152 | $116.75 | -5.0% | May 6, 2024 |
| Wells Fargo | Roger Read | $142 | $118.27 | -11.2% | Apr 30, 2024 |
| HSBC | Kim Fustier | $120 | $119.64 | -25.0% | Apr 30, 2024 |
| Piper Sandler | Ryan Todd | $145 | $118.63 | -9.4% | Apr 18, 2024 |
| UBS | Josh Silverstein | $150 | $122.2 | -6.2% | Apr 11, 2024 |
| Jefferies | Lloyd Byrne | $140 | $121.37 | -12.5% | Apr 8, 2024 |
| Truist Financial | Neal Dingmann | $146 | $120.31 | -8.7% | Apr 5, 2024 |
| Wells Fargo | Roger Read | $138 | $119.3 | -13.7% | Apr 4, 2024 |
| UBS | Jon Rigby | $132 | $102.39 | -17.5% | Feb 2, 2024 |
| Bernstein | Bob Brackett | $139 | $109.11 | -13.1% | Nov 2, 2023 |
| Redburn Partners | Peter Low | $105 | $107.6 | -34.4% | Oct 27, 2023 |
| Piper Sandler | Ryan Todd | $46 | $108.99 | -71.2% | Oct 6, 2023 |
| Mizuho Securities | Nitin Kumar | $139 | $109.04 | -13.1% | Oct 5, 2023 |
| Morgan Stanley | Devin McDermott | $131 | $116.18 | -18.1% | Sep 25, 2023 |
| RBC Capital | Biraj Borkhataria | $120 | $114.76 | -25.0% | Sep 21, 2023 |
| Morgan Stanley | Devin McDermott | $122 | $110.31 | -23.7% | May 2, 2023 |
| Goldman Sachs | Neil Mehta | $125 | $115.3 | -21.9% | May 1, 2023 |
| Argus Research | Bill Selesky | $133 | $111.54 | -16.9% | Mar 8, 2023 |
| Cowen & Co. | Analyst unavailable | $113 | $112.21 | -29.4% | Feb 2, 2023 |
| Wells Fargo | Analyst unavailable | $125 | $115.72 | -21.9% | Feb 1, 2023 |
| Truist Financial | Analyst unavailable | $110 | $116.01 | -31.2% | Feb 1, 2023 |
| Wells Fargo | Analyst unavailable | $122 | $109.25 | -23.7% | Jan 10, 2023 |
| Barclays | Analyst unavailable | $129 | $109.11 | -19.4% | Jan 3, 2023 |
| Piper Sandler | Analyst unavailable | $127 | $104.7 | -20.6% | Dec 19, 2022 |
| Piper Sandler | Analyst unavailable | $131 | $110.5 | -18.1% | Nov 11, 2022 |
| Wells Fargo | Roger Read | $109 | $102.06 | -31.9% | Oct 7, 2022 |
| Piper Sandler | Analyst unavailable | $108 | $98.41 | -32.5% | Sep 12, 2022 |
| Morgan Stanley | Analyst unavailable | $113 | $95.05 | -29.4% | Sep 6, 2022 |
| HSBC | Gordon Gray | $97.5 | $91.02 | -39.1% | Aug 3, 2022 |
| Morgan Stanley | Analyst unavailable | $106 | $87.35 | -33.7% | Jul 19, 2022 |
| Truist Financial | Analyst unavailable | $83 | $87.64 | -48.1% | Jul 19, 2022 |
| Credit Suisse | Manav Gupta | $125 | $85.64 | -21.9% | Jun 30, 2022 |
| Goldman Sachs | Neil Mehta | $117 | $100.46 | -26.9% | Jun 10, 2022 |
| Credit Suisse | Analyst unavailable | $115 | $98.84 | -28.1% | Jun 7, 2022 |
| Evercore ISI | Kirk Materne | $120 | $98.84 | -25.0% | Jun 7, 2022 |
| Morgan Stanley | Analyst unavailable | $107 | $99.09 | -33.1% | Jun 6, 2022 |
| Barclays | Jeanine Wai | $111 | $96.18 | -30.6% | May 31, 2022 |
| Argus Research | Bill Selesky | $104 | $84.46 | -35.0% | May 10, 2022 |
| Credit Suisse | Manav Gupta | $102 | $86.41 | -36.2% | May 3, 2022 |
| Truist Financial | Neal Dingmann | $84 | $84.1 | -47.5% | Apr 26, 2022 |
| Morgan Stanley | Analyst unavailable | $103 | $86.78 | -35.6% | Apr 22, 2022 |
| RBC Capital | Analyst unavailable | $100 | $87.96 | -37.5% | Apr 21, 2022 |
| Jefferies | Giacomo Romeo | $81 | $83.65 | -49.4% | Apr 6, 2022 |
| Wells Fargo | Roger Read | $107 | $76.93 | -33.1% | Mar 16, 2022 |
| MKM Partners | John Gerdes | $84 | $84.09 | -47.5% | Mar 4, 2022 |
| Truist Financial | Neal Dingmann | $75 | $81.04 | -53.1% | Mar 3, 2022 |
| Piper Sandler | Ryan Todd | $87 | $81.04 | -45.6% | Mar 3, 2022 |
| BMO Capital | Phillip Jungwirth | $86 | $81.04 | -46.2% | Mar 3, 2022 |
| Goldman Sachs | Neil Mehta | $91 | $80.53 | -43.1% | Mar 2, 2022 |
| Citigroup | Alastair Syme | $80 | $80.53 | -50.0% | Mar 2, 2022 |
| Bank of America Securities | Doug Leggate | $110 | $79.17 | -31.2% | Mar 1, 2022 |
| Credit Suisse | Manav Gupta | $90 | $75.8 | -43.7% | Feb 24, 2022 |
| Cowen & Co. | Jason Gabelman | $77 | $76.77 | -51.9% | Feb 23, 2022 |
| Evercore ISI | Stephen Richardson | $88 | $79.74 | -45.0% | Feb 2, 2022 |
| Argus Research | Bill Selesky | $92 | $79.74 | -42.5% | Feb 2, 2022 |
| Morgan Stanley | Devin McDermott | $95 | $79.74 | -40.6% | Feb 2, 2022 |
| Wolfe Research | Sam Margolin | $93 | $79.94 | -41.9% | Feb 1, 2022 |
| UBS | Jon Rigby | $77 | $74.45 | -51.9% | Jan 28, 2022 |
| BNP Paribas | Lucas Herrmann | $60 | $60.08 | -62.5% | Oct 11, 2021 |
| DZ BANK AG | Werner Eisenmann | $62.5 | $55.95 | -60.9% | Aug 3, 2021 |
Track every rating change on XOM the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationExxon Mobil Corporation is a global energy firm that undertakes the exploration and extraction of oil and natural gas resources across its domestic operations and international territories. The company organizes its vast activities into three primary divisions: Upstream, Downstream, and Chemical. Beyond resource acquisition, Exxon Mobil is deeply engaged in the manufacturing, commercial trading, logistical transportation, and marketing of crude oil, natural gas, refined petroleum goods, a wide array of petrochemicals (including olefins, polyolefins, and aromatics), and other specialized chemical products. Furthermore, the company is actively developing solutions in carbon capture and storage, hydrogen, and biofuels. Founded in 1870, Exxon Mobil's corporate headquarters are located in Irving, Texas.
Historical context
All XOM earningsEnergy peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| EC Ecopetrol S.A. | FY2026 Q3 · Calendar Q4 2026 | -5.6% | +0.7% | Ecopetrol Q3: Record refining margins and Brava lift results |
| PBR-A Petróleo Brasileiro S.A. - Petrobras | FY2026 Q3 · Calendar Q4 2026 | +9.1% | — | Petrobras lifts production and CapEx outlook as output reaches a record |
| PBR Petróleo Brasileiro S.A. - Petrobras | FY2026 Q3 · Calendar Q4 2026 | -13.0% | -2.5% | Petrobras sets Q3 production record and raises 2026 output guidance |
| VG Venture Global, Inc. | FY2026 Q3 · Calendar Q4 2026 | +92.7% | +1.7% | Venture Global raises 2026 outlook as AI-power plans add execution questions |
Latest beats and misses
Who reports nextBeat on EPS
- INTUFY2027 Q1 · November 19, 2026+18.3% EPS-6.2% move
- ROSTFY2026 Q3 · November 19, 2026+2.1% EPS-2.8% move
- ESTCFY2027 Q2 · November 19, 2026+16.2% EPS+2.0% move
- KEYSFY2026 Q4 · November 19, 2026+7.1% EPS-1.5% move
- WSMFY2026 Q3 · November 19, 20260.0% EPS-15.2% move
- WMGFY2026 Q4 · November 19, 2026+50.9% EPS-0.6% move
Missed on EPS
- NTESFY2026 Q3 · November 19, 2026-12.8% EPS-11.4% move
- FUTUFY2026 Q3 · November 19, 2026-7.8% EPS+4.8% move
- BABAFY2027 Q2 · November 19, 2026-29.2% EPS-1.3% move
- SQMFY2026 Q3 · November 17, 2026-3.0% EPS-5.5% move
- VIKFY2026 Q3 · November 17, 2026-12.6% EPS+4.4% move
- XPFY2026 Q3 · November 16, 2026-3.0% EPS-2.5% move
Get the XOM recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-10-17T05:10:49.140638+00:00
- Polygon adjusted daily market bars · 2026-11-16T10:50:46.796805+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-16T10:50:46.794086+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-16. For educational purposes only; not investment advice.